Cite
HARVARD Citation
Greuther, T. et al. (n.d.). OP037 Risk of cancer in inflammatory bowel disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors: a cross-sectional and follow-up analysis of the Swiss IBD cohort study. Journal of Crohn's and colitis. pp. S026-S027. [Online].